Retinal Pigment Epithelial Cells in Research and Clinical Applications

In this webinar, Dr. Kapil Bharti (National Eye Institute, NIH) discussed the use of induced pluripotent stem (iPS) cell technology to develop in vitro disease models to study patient-specific disease processes, to set up high throughput drug screens, and to develop cell-based therapy for retinal degenerative disease.
Topics covered:
Characterization of iPSC-derived retinal pigment epithelium (RPE)
iPSC-derived RPE for ocular disease modeling
iPSC-derived RPE in clinical applications